TherapeuticsMD, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 0.437 million compared to USD 0.348 million a year ago. Net loss was USD 2.41 million compared to net income of USD 112.28 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 1.7 a year ago. Diluted loss per share from continuing operations was USD 0.24 compared to USD 1.7 a year ago. Basic loss per share was USD 0.24 compared to basic earnings per share of USD 12.83 a year ago. Diluted loss per share was USD 0.24 compared to diluted earnings per share of USD 12.83 a year ago.
For the six months, revenue was USD 0.853 million compared to USD 1.04 million a year ago. Net loss was USD 6.02 million compared to net income of USD 63.26 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to USD 3.77 a year ago. Diluted loss per share from continuing operations was USD 0.47 compared to USD 3.77 a year ago. Basic loss per share was USD 0.6 compared to basic earnings per share of USD 7.29 a year ago. Diluted loss per share was USD 0.6 compared to diluted earnings per share of USD 7.29 a year ago.